期刊文献+

生酮饮食对难治性癫痫患儿滤泡辅助性T细胞及B细胞的影响

The mechanism of hypogammaglobuinemia caused by ketongenic diet
原文传递
导出
摘要 目的:探讨生酮饮食( KD )导致低丙种球蛋白血症的可能机制。方法难治性癫痫( IP)患儿36例,正常同龄对照17例,分别于KD治疗前后直接取血备检。流式细胞术检测外周血滤泡辅助性T细胞( Tfh)、各阶段B细胞比例,ELISA检测外周血IL-21浓度,实时荧光定量PCR检测外周血CD4+T细胞雷帕霉素靶蛋白( mTOR )、Blimp-1、Bcl-6和IL-21 mRNA表达及测定CD19细胞mTOR mRNA表达。结果(1)IP患儿Tfh细胞数量在KD治疗后明显下降(P<0.05),IP患儿治疗前Tfh细胞比例与正常对照组无明显差异(P>0.05)。(2)IP患儿KD治疗后Tfh细胞转录因子Bcl-6表达显著下降(P<0.05),抑制因子Blimp-1表达增高(P<0.05)。(3)KD治疗后IP患儿IL-21血浓度呈下降趋势,CD4+T细胞IL-21 mRNA表达显著下降(P<0.05)。(4)KD治疗前后CD27-IgD+B细胞无显著差异(P>0.05),CD27+IgD+B细胞和CD27-IgD-B细胞呈下降趋势,CD27+IgD-B细胞和CD27+IgD-CD38highB细胞治疗后明显下降(P<0.05),Tfh细胞比例与CD27+IgD-转化后记忆B细胞和CD27+IgD-CD38high浆细胞数量呈正相关(r分别为0.644和0.609,P<0.05)。(5)IP患儿KD治疗后CD4+T细胞mTOR mRNA表达显著下降(P<0.05),mTOR表达与Tfh比例呈正相关(r=0.691,P<0.05),mTOR表达与CD27+IgD-转化后记忆B细胞和CD27+IgD-CD38high浆细胞数量呈正相关(r分别为0.715和0.650,P<0.05)。结论 KD可通过抑制CD4+T细胞及B细胞mTOR表达下调Tfh细胞数量及功能,抑制B细胞分化,这可能是少数患儿长期KD治疗导致低丙种球蛋白血症的原因之一。 Objective To investigate the possible mechanism of hypogammaglobuinemia caused by ketongenic diet (KD).Methods Thirty-six children with intractable epilepsy (IP) and seventeen age-matched healthy children were recruited in this study.The percentages of B cells at various stages of devel-opment and follicular helper T ( Tfh) cells were detected by flow cytometry.The plasma concentrations of IL-21 were determined by ELISA.Real-time quantitative PCR was performed to detect the expression of mam-malian target of rapamycin ( mTOR) , Blimp-1, Bcl-6 and IL-21 at mRNA level in CD4+T cells.Results mTOR at mRNA level was significantly down-regulated after KD treatment (P〈0.05).The numbers of Tfh cells were positively correlated with the transcriptional level of mTOR (r=-0.691, P〈0.05).Conclusion KD treatment might down-regulate Tfh and B cells through suppressing the expression of mTOR at mRNA level, suggesting a possible mechanism of hypogammaglobuinemia induced by KD treatment.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2014年第11期817-824,共8页 Chinese Journal of Microbiology and Immunology
基金 深圳市科技计划项目(201103147)
关键词 生酮饮食 雷帕霉素靶蛋白 B细胞 滤泡辅助性T细胞 IL-21 BCL-6 BLIMP-1 Ketogenic diet Mammalian target of rapamycin B-lymphocytes Follicular helper T cells IL-21 Bcl-6 Blimp-1
  • 相关文献

参考文献19

  • 1廖建湘.生酮饮食在儿童癫治疗中的应用进展[J].实用儿科临床杂志,2007,22(24):1847-1849. 被引量:20
  • 2Ketogenic Diet Study Group of the Subspecialty Group of Neurolo-gy, the Society of Pediatrics, Chinese Medical Association. Pro-spective multicenter study on long-term ketogenic diet therapy forintractable childhood epilepsy [ J ]. Zhonghua Er Ke Za Zhi,2013, 51(4) : 276-282.
  • 3Crotty S. Follicular helper CD4 T cells (Tfh) [ J]. Annu Rev Im-munoi, 2011, 29: 621-663.
  • 4Klein U, Dalla-Favera R. Germinal centres: role in B-cell physi-ology and malignancy [ J]. Nat Rev Immunol, 2008 , 8(1): 22-33.
  • 5Ma CS, Deenick EK. Human T follicular helper (Tfh) cells anddisease[ J] . Immunol Cell Biol, 2014, 92(1) : 64-71.
  • 6Zeng H, Chi H. mTOR and lymphocyte metabolism [ J]. CurrOpin Immunol, 2013,25(3) : 347-355.
  • 7McDaniel SS, Reusing NR, Thio LL, et al. The ketogenic diet in-hibits the mammalian target of rapamycin ( mTOR) pathway [ J ] .Epilepsia, 2011,52(3) : e7-11.
  • 8Shirota Y, Yarboro C, Fischer R, et al. Impact of anti-interleu-kin-6 receptor blockade on circulating T and B cell subsets in pa-tients with systemic lupus erythematosus [ J ] . Ann Rheum Dis,2013,72(1) : 118-128.
  • 9Suo C, Liao J, Lu X,et al. Efficacy and safety of the ketogenicdiet in Chinese children[ J]. Seizure, 2013 , 22(3 ) : 174-178.
  • 10McHeyzer-Williams LJ, Pelletier N, Mark L, et al. Follicularhelper T cells as cognate regulators of B cell immunity[ J]. CurrOpin Immunol, 2009, 21(3) : 266-273.

二级参考文献14

  • 1Kossoff EH, McGrogan JR. Worldwide use of the ketogenic diet [ J ]. Epilepsia,2005,46 (2) :280 - 289.
  • 2Huffman J,Kossoff EH. State of the ketogenic diet(s) in epilepsy[J]. Curr Neurol Neur Rep,2006, 6(4) :332 -340.
  • 3Keene DL. A systematic review of the use of the ketogenic diet in childhood epilepsy [ J ]. Pediatr Neurol,2006 ,35 ( 1 ) : 1 - 5.
  • 4Freeman J, Vining E, Pillas D J, et al. The efficacy of the ketogenic diet-1998: A prospective evaluation of intervention in 150 children [ J ]. Pediatrics, 1998,102 (6) : 1358 - 1363.
  • 5Vining E, Freeman J, Ballaban - Gil K, et al. A multicenter study of the efficacy of the ketogenic diet [ J ]. Ach Neurol, 1998,55 ( 11 ) : 1433 - 1437.
  • 6Kang HC, Kim YJ, Kim DW,et al. Efficacy and safety of the ketogenic diet for intractable childhood epilepsy: Korean multicentric experience [ J ]. Epilepsia, 2005,46 ( 2 ) : 272 - 279.
  • 7Kossoff EH, Pyzik PL, McGrogan JR, et al. Efficacy of the ketogenic diet for infantile spasms[ J]. Pediatrics ,2002,109(5 ) :780 - 783.
  • 8Hartman AL, Vining EPG. Clinical aspects of the ketogenic diet [ J ]. Epilepsia,2007,48( 1 ) :31 -42.
  • 9Kang HC, Chung DE, Kim DW,et al. Early- and late-onset complications of the ketogenic diet for intractable epilepsy [ J ]. Epilepsia ,200d, 45(9) :1116 - 1123.
  • 10Pfeifer HH ,Thiele EA. Low - glycemic - index treatment : A liberalized ketogenic diet for treatment of intractable epilepsy [ J ]. Neurology, 2005,65( 11 ) :1810 - 1812.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部